We verified that USP39 expression was associated with tumor grade, independent from other clinicopathological factors, including age, gender, tumor size, cystic change, and edema, which suggested that USP39 could be a potential diagnostic factor for glioma patients (Table 1, p < 0.05). The gene discussed is USP39; the disease is neoplasm.